M. Girndt et al., TETANUS IMMUNIZATION AND ITS ASSOCIATION TO HEPATITIS-B VACCINATION IN PATIENTS WITH CHRONIC-RENAL-FAILURE, American journal of kidney diseases, 26(3), 1995, pp. 454-460
A defect in the immune response of patients with chronic renal failure
leads to low response rates and insufficient antibody concentrations
following a number of highly recommended vaccinations, This has been s
hown before for immunization against hepatitis B and influenza. Few da
ta are available concerning the efficacy of vaccination with tetanus t
oroid in these patients, In a prospective, controlled study we vaccina
ted seronegative patients with chronic renal failure not on dialysis,
patients on chronic intermittent hemodialysis, and patients after kidn
ey transplantation with tetanus toroid, The results were compared with
those of a control group consisting of 13 age-matched patients with m
ild essential hypertension and normal kidney function, Only 11 of 20 (
55%) patients in the chronic renal failure group and 16 of 23 (69%) in
the dialysis group had a protective antibody response after triple va
ccination, In contrast, all the patients in the control group and six
of seven transplant patients seroconverted, The response to tetanus to
roid was highly associated with the response to a previously administe
red vaccination against hepatitis B. Responders to this vaccination al
so had a better response rate to tetanus toroid. The antibody concentr
ations after vaccination were lower in all patient groups compared wit
h the controls; the lowest titers were found in the transplant patient
s, Therefore, renal patients will need revaccination much earlier, and
tetanus toroid antibody levels should be checked if a patient is inju
red and potentially requires vaccination. (C) 1995 by the National Kid
ney Foundation, Inc.